Pain News and Research

Latest Pain News and Research

AHR panel calls for greater research to establish connection between creative engagement and cardiac health

The Foundation for Art & Healing today releases the proceedings from its groundbreaking Arts and the Heart Roundtable (AHR), a gathering of luminaries from the medical, arts and public health sectors regarding the connection between creative engagement and cardiac health.

2 Apr 2010

Xanodyne Pharmaceuticals, Ferring Pharmaceuticals sign co-promotion agreement for Zipsor

Xanodyne Pharmaceuticals, Inc., an integrated specialty pharmaceutical company with both development and commercial capabilities focused on women's healthcare and pain management, today announced that it has signed a co-promotion agreement for Zipsor™ (diclofenac potassium) Liquid Filled Capsules with Ferring Pharmaceuticals Inc., a global bio-pharmaceutical company, headquartered in Switzerland.

1 Apr 2010

Pro-Vas male contraceptive procedure available to physicians across the U.S.

Pro-Vas is the first male contraceptive procedure, other than condoms or vasectomy, to provide effective affordable birth control for men and it is available to physicians across the United States immediately.

1 Apr 2010

With corporations already claiming pain from overhaul, business lobby prepares to fight back

A week after the health overhaul cleared Congress, a business lobby that opposed the plan is now regrouping to shape its implementation and exact political retribution on supporters, The Wall Street Journal reports. "The U.S. Chamber of Commerce is planning a broad effort to blunt the health overhaul by trying to shape its regulatory language and spending heavily to unseat vulnerable Democrats who voted for it."

1 Apr 2010

Lifetime Television to feature XenaCare Holdings' OTC pain reliever Cobroxin

XenaCare Holdings, Inc., a company specializing in the marketing and retail distribution of consumer healthcare products, has announced today that its over-the-counter (OTC) pain reliever, Cobroxin, will be featured on a segment of The Balancing Act, a morning show that airs on the top-rated women's cable television network, Lifetime Television.

1 Apr 2010

Conventional analgesics to drive acute pain market over the next decade

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, through 2018, the launches and uptake of reformulations of conventional analgesics will drive annual three percent growth in the acute pain drug market in the United States, France, Germany, Italy, Spain, the United Kingdom and Japan.

1 Apr 2010

Immediate access to life-saving first aid medical database

GotoAID.com is on a big mission -- to give every person on earth immediate access to first aid for emergencies with the use of technology. As the Internet is quickly becoming more accessible to people with a computer or web-capable mobile device, GotoAID is bringing a life-saving first aid medical database to the masses.

1 Apr 2010

Levator ani syndrome: Biofeedback more effective than EGS or digital massage

A new study conducted by Italian researchers, in collaboration with the University of North Carolina at Chapel Hill, finds that biofeedback is more effective than two other treatments for a type of chronic rectal pain called levator ani syndrome.

1 Apr 2010

Leg length inequality linked to osteoarthritis: Study

A new study shows that arthritis in the knee is linked to the common trait of having one leg that is longer than the other. Whether or not leg length differential is a direct cause of osteoarthritis is not clear, but the findings may allow people to take preventive measures before the onset of the chronic and painful condition.

1 Apr 2010

Positive results from Phase 2 clinical trial of OMS103HP

Omeros Corporation today announced that a Phase 2 clinical trial of OMS103HP, its PharmacoSurgery™ product candidate for arthroscopy, demonstrated that patients treated with OMS103HP during arthroscopic knee meniscectomy surgery achieved statistically significant clinical benefits.

1 Apr 2010

New medicines to fight diseases of particular concern to African Americans

A recent article in The Triangle Tribune pointed to good news for members of the black community, highlighting new medicines in development to fight diseases of particular concern to African Americans.

1 Apr 2010

Tanda Professional Restore light therapy now made available for at-home use

During a press conference yesterday, doctors and experts unveiled a groundbreaking medical device using the healing properties of light therapy for pain management and improving mobility. For the first time ever, a licensed medical device that delivers clinical levels of light therapy only previously available in a doctor's office, has now been made available for at-home use.

1 Apr 2010

Collegium Pharmaceutical receives USPTO notice of allowance for novel formulation of milnacipran

Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its patent application "Modified Release Compositions of Milnacipran", US Patent Application Number 12/211,780. The Notice of Allowance is the USPTO's official communication that the Company's application has successfully completed examination and that a patent will be issued.

31 Mar 2010

Recipients of Pfizer Canada's third Neuropathic Pain Research Awards Competition announced

Pfizer Canada is pleased to announce the recipients of its third Neuropathic Pain Research Awards Competition, which aims to fund and support Canadian innovation within independent neuropathic pain research in the areas of basic biomedical, clinical and health sciences.

31 Mar 2010

Study comparing Plasma Disc Decompression with epidural steroid injections for lumbar disc herniation

ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, announced today the publication of an important clinical trial demonstrating that patients treated with ArthroCare's Plasma Disc Decompression (PDD) products experienced reduced pain and better quality of life scores compared to patients treated with the current standard care, epidural steroid injections.

31 Mar 2010

TNS signs revenue sharing agreement to launch dietary supplement products in USA

Total Nutraceutical Solutions, Inc announced today that the company has entered into a revenue sharing agreement to undertake a direct mail marketing program of a proprietary private label compound developed and manufactured by the company for joint pain and inflammation.

31 Mar 2010

Does your insurance policy covers emergency expenses abroad?

You're on the sunny shores of Aruba enjoying your dream vacation. Suddenly, you have excruciating pain in your abdomen. You're rushed to the local hospital where they run tests and diagnose you with appendicitis.

31 Mar 2010

New anti-inflammatory drug shows promise for treating inflammatory disorders

Aspirin, ibuprofen and other non-steroidal anti-inflammatory drugs (NSAIDs) remain the most common treatment to relieve symptoms of arthritis and other inflammatory disorders. But despite their widespread use (around 2.5 million Canadians have osteoarthritis) these medications are also known to cause severe, sometimes life-threatening adverse effects within the body, particularly in the gastrointestinal tract

31 Mar 2010

WOCN Society launches campaign to raise awareness about benefits of specialized care

Patients and families who are dealing with conditions such as non-healing wounds, bedsores, bladder and bowel incontinence and ostomy-related issues contend with physical symptoms, as well as social and emotional side effects. The impact on patients and families can exact an enormous toll. The Wound Ostomy & Continence Nurses Society is launching a campaign to raise awareness about the benefits of specialized care.

31 Mar 2010

PMDD often misdiagnosed as major depression or other mood disorder

As science slowly, but continually, unravels the causes of disorders, it increasingly teases apart biological threads that, when spooled together, begin to take on the warp and weft of separate disorders.

31 Mar 2010

Pain News and Research

Latest Pain News and Research

AHR panel calls for greater research to establish connection between creative engagement and cardiac health

Xanodyne Pharmaceuticals, Ferring Pharmaceuticals sign co-promotion agreement for Zipsor

Pro-Vas male contraceptive procedure available to physicians across the U.S.

With corporations already claiming pain from overhaul, business lobby prepares to fight back

Lifetime Television to feature XenaCare Holdings' OTC pain reliever Cobroxin

Conventional analgesics to drive acute pain market over the next decade

Immediate access to life-saving first aid medical database

Levator ani syndrome: Biofeedback more effective than EGS or digital massage

Leg length inequality linked to osteoarthritis: Study

Positive results from Phase 2 clinical trial of OMS103HP

New medicines to fight diseases of particular concern to African Americans

Tanda Professional Restore light therapy now made available for at-home use

Collegium Pharmaceutical receives USPTO notice of allowance for novel formulation of milnacipran

Recipients of Pfizer Canada's third Neuropathic Pain Research Awards Competition announced

Study comparing Plasma Disc Decompression with epidural steroid injections for lumbar disc herniation

TNS signs revenue sharing agreement to launch dietary supplement products in USA

Does your insurance policy covers emergency expenses abroad?

New anti-inflammatory drug shows promise for treating inflammatory disorders

WOCN Society launches campaign to raise awareness about benefits of specialized care

PMDD often misdiagnosed as major depression or other mood disorder

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Pain News and Research

Latest Pain News and Research

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in